Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Discovery of drug mode of action and drug repositioning from transcriptional responses

Open access
Iorio, Francesco, Bosotti, Roberta, Scacheri, Emanuela, Belcastro, Vincenzo, Mithbaokar, Pratibha, Ferriero, Rosa, Murino, Loredana, Tagliaferri, Roberto, Brunetti-Pierri, Nicola, Isacchi, Antonella, di Bernardo, Diego·2010·Proceedings of the National Academy of Sciences

Abstract

A bottleneck in drug discovery is the identification of the molecular targets of a compound (mode of action, MoA) and of its off-target effects. Previous approaches to elucidate drug MoA include analysis of chemical structures, transcriptional responses following treatment, and text mining. Methods based on transcriptional responses require the least amount of information and can be quickly applied to new compounds. Available methods are inefficient and are not able to support network pharmacology. We developed an automatic and robust approach that exploits similarity in gene expression profiles following drug treatment, across multiple cell lines and dosages, to predict similarities in drug effect and MoA. We constructed a “drug network” of 1,302 nodes (drugs) and 41,047 edges (indicating similarities between pair of drugs). We applied network theory, partitioning drugs into groups of densely interconnected nodes (i.e., communities). These communities are significantly enriched for compounds with similar MoA, or acting on the same pathway, and can be used to identify the compound-targeted biological pathways. New compounds can be integrated into the network to predict their therapeutic and off-target effects. Using this network, we correctly predicted the MoA for nine anticancer compounds, and we were able to discover an unreported effect for a well-known drug. We verified an unexpected similarity between cyclin-dependent kinase 2 inhibitors and Topoisomerase inhibitors. We discovered that Fasudil (a Rho-kinase inhibitor) might be “repositioned” as an enhancer of cellular autophagy, potentially applicable to several neurodegenerative disorders. Our approach was implemented in a tool (Mode of Action by NeTwoRk Analysis, MANTRA, http://mantra.tigem.it ).

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.1000138107

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. U Schwabe ATC-Code (Wissenschaftliches Institut der AOK, Bonn, Germany, 1995).

Cited by

See all 816

Metadata

Authors
Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., & di Bernardo, D.
Affiliations
  • University of Salerno (IT)
  • Nerviano Medical Sciences (IT)
  • Telethon Institute Of Genetics And Medicine (IT)
  • TeleThon Institute of Genetics and Medicine, Naples, Italy;
Venue
Proceedings of the National Academy of Sciences
Published
2010-08-02
Volume
107
Issue
33
Pages
14621-14626
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2094791588
Cited by
816
References
46
Citations by year
2026: 18 · 2025: 33 · 2024: 26 · 2023: 53 · 2022: 42 · 2021: 51 · 2020: 53 · 2019: 72 · 2018: 64 · 2017: 52 · 2016: 77 · 2015: 72 · 2014: 54 · 2013: 57 · 2012: 58
FWCI
48.11
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Fondazione Telethon (TCBP37TELC)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
Keywords
drug mode of action, drug repurposing, transcriptional response, gene expression profiles, drug networks, community detection, off-target effects, anticancer agents, topoisomerase inhibitors, fasudil, autophagy, neurodegenerative diseases, network pharmacology, mantras
MeSH terms
Irinotecan, Algorithms, Antineoplastic Agents, Autophagy, Camptothecin, Doxorubicin, Drug Screening Assays, Antitumor, Flavonoids, HeLa Cells, Humans, Neoplasms, Phosphorylation, Piperidines, Pyrazoles, Pyrroles, RNA Polymerase II, Blotting, Western, Gene Expression Regulation, Neoplastic, Fuzzy Logic, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Cell Line, Tumor, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of drug mode of action and drug repositioning from transcriptional responses. https://app.cochat.ai/papers/10.1073/pnas.1000138107
The paper
Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., & di Bernardo, D. (2010). Discovery of drug mode of action and drug repositioning from transcriptional responses. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1000138107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.